About Dr. Akanksha Gautam

Dr. Akanksha Gautam, an endocrinology specialist, received her training at the esteemed PGIMER, Chandigarh. With over 6 years of experience in the field, she has served at GMCH Chandigarh, JPNATC, AIIMS New Delhi, and Safdarjung Hospital New Delhi. Her expertise encompasses diabetes, thyroid disorders, PCOD, short stature, pubertal disorders, pituitary disorders, calcium abnormalities, and osteoporosis. Dedicated to delivering comprehensive healthcare, she remains committed to integrating the latest advancements in endocrinology into her practice.

Work Experience

• Working as a Consultant Endocrinologist at Livasa Hospital, Mohali

Previously worked as:

• Senior Resident (Endocrinology) in PGIMER Chandigarh 2019-2022
• Senior Resident (Endocrinology) in the Department of Endocrinology, VMMC and Safdarjung Hospital, New Delhi in 2017-2018
• Senior Resident (Medicine) in the Department of Emergency Medicine, JPNATC AIIMS, New Delhi in 2016-2017
• Senior Resident (Medicine) in the Department of Medicine, GMCH Chandigarh in 2015-2016
• Consultant Endocrinologist at Gini Health, Sector 69 Mohali July 2022 to December 2022
• Consultant Endocrinologist at Neelam Hospital, Rajpura January 2023 to August 2023

Education & Training

• Secondary School Certificate Examination from Mount Carmel School, Palampur affiliated to ICSE New Delhi 2004.
• Higher Secondary Certificate Examination from Sacred Heart Sr. Sec. School, Chandigarh affiliated to CBSE New Delhi 2007.
• MBBS from Government Medical College and Hospital, Chandigarh 2006- 2011
• MD (Internal Medicine) from Indira Gandhi Medical College, Shimla 2012- 2015
• DM (Endocrinology) from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh January 2019-June 2022

Memberships

• Endocrine Society
• European Society of Endocrinology
• ISBMR
• Endocrine Society of Himachal Pradesh

Awards

• Oral presentation at the 24th European Congress in Endocrinology held at Milan, Italy in May 2022 on the topic “Impact of preoperative Zoledronic acid On hungry bone syndrome and bone health indices in patients with primary Hyperparathyroidism after curative thyroidectomy a randomized controlled trial”
• First prize in e-poster presentation in ISBMR 2021, held at Hyderabad
• Presented poster on the topic “Bone mineral density and its predictors in type 2 diabetes mellitus: a cross-sectional study from tertiary care institute from North India”.

Speciality Interest

• Diabetes Mellitus-adults and children
• Thyroid disorder
• PCOD
• Osteoporosis
• Parathyroid Disorder

Research Paper & Publications

• Muthuvel B, Gautam A, Pal R, Panigrahi 1, Dayal D. Simple virilising congenital adrenal hyperplasia in monozygotic twins: A rare report and review of previous cases. Pediatr Endocrinol Diabetes Metab. 2020;26(1):58-62. English. Doi: 10.5114/pedm. 2020.93248. PMID: 32272826.
• Solanki D, Walia R, Gautam A, Misra A, Aggarwal A, Bhansali A. Prevalence of abdominal obesity in non-obese adolescents: a North Indian adolescent study, Journal of Pediatric Endocrinology and Metabolism. 2020;33(7): 853-858. https://doi.org/10.1515/jpem-2019-0026
• Pal R, Gautam A, Bhadada SK. Role of bisphosphonates in the prevention of postoperative hungry bone syndrome in primary hyper-parathyroidism: a meta-analysis and need for randomized controlled trials. Drug Res. 2021:71(2):108-109. Doi:10.1055/a-1325-0351
• Dahiya D, Abuji K, Kumari P, Gautam A, Bhadada SK, Sood A, Saikia U, Tandup C, Behera A. (2021). Surgical outcome after focused parathyroidectomy: an experience from a tertiary care center in north India. Polish Journal of Surgery. 93. 1-5. 10.5604/01.3001.0014.8864.cm
• Gautam A, Bhadada SK, Bhansali A, Dahiya D, Behera A, Saikia U, Sood A, Singh T. (2022). Impact of preoperative zoledronic acid on hungry bone syndrome and bone health indices in patients with primary hyperparathyroidism after curative parathyroidectomy: a randomized controlled trial. Endocrine Abstracts. 10.1530/endoabs.81.0C8.3.
• Gautam A, Rastogi A, Bhadada SK. GIANT MEDIASTINAL PARATHYROID ADENOMAS AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 1: A DIAGNOSTIC CONUNDRUM. Acta Endocrinol (Buchar). 2022 Jan- Mar, 18(1):118-123. Doi: 10.4183/aeb. 2022.118. PMID: 35975263; PMCID: PMC9365420.